🟩 5/28일자 벨기에,프랑스 계약 소식

유럽연합의 온라인 조달관보인 TED(Tenders Electronic Daily)에서 5/28일자 벨기에,프랑스 계약 낙찰 공고가 3건 확인되네요

1️⃣ 315061-2024 벨기에

2️⃣ 314743-2024 프랑스

3️⃣ 313638-2024 벨기에

약품명은 RITUXIMAB (트룩시마), TRASTUZUMAB (허쥬마)로 확인됩니다. 낙찰금액은 각각3억1500, 30억, 4억정도로 확인

됩니다 자세한 내용은 첨부 및 아래내용을 참고하세요

1️⃣ 315061-2024 벨기에

RES-0001: At least one winner was chosen.

Maximum value of the framework agreement: 836 000,00 EUR

Tender identifier: Celltrion Healthcare Netherlands B.V.

Identifier of lot or group of lots: LOT-0001

□ Value of the result: 213 404,80 EUR

Identifier of the contract: 1439-1989

□ RITUXIMAB IV

□ Date of the conclusion of the contract: 14/05/2024

□ Winner: Celltrion Healthcare Netherlands B.V.

Netherlands, Amsterdam

2️⃣ 314743-2024 프랑스

RES-0005: At least one winner was chosen.

Maximum value of the framework agreement: 2 049 900,00 EUR

Tender identifier: offre société CELLTRION HEALTHCARE FRANCE SAS

Identifier of lot or group of lots: LOT-0002

□ Value of the result: 2 049 900,00 EUR (30억)

Identifier of the contract: 240107

□ Date of the conclusion of the contract: 16/04/2024

□ Winner: CELLTRION HEALTHCARE FRANCE SAS

3️⃣ 313638-2024 벨기에

RES-0001: At least one winner was chosen.

Maximum value of the framework agreement: 768 000,00 EUR

Tender identifier: Celltrion Healthcare Netherlands B.V.

Identifier of lot or group of lots: LOT-0001

□ Value of the result: 271 104,00 EUR

Identifier of the contract: 1367-1971

□ TRASTUZUMAB IV

□ Date of the conclusion of the contract: 14/05/2024

□ Winner: Celltrion Healthcare Netherlands B.V.

Netherlands, Amsterdam